Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein can elicit a protective immune response against a genital challenge
about
Surface expression, single-channel analysis and membrane topology of recombinant Chlamydia trachomatis Major Outer Membrane ProteinCaveolin-2 associates with intracellular chlamydial inclusions independently of caveolin-1Recombinant expression of Chlamydia trachomatis major outer membrane protein in E. Coli outer membrane as a substrate for vaccine researchProtection against Chlamydia promoted by a subunit vaccine (CTH1) compared with a primary intranasal infection in a mouse genital challenge model.Production of a proteolytically active protein, chlamydial protease/proteasome-like activity factor, by five different Chlamydia species.Chlamydia muridarum T-cell antigens formulated with the adjuvant DDA/TDB induce immunity against infection that correlates with a high frequency of gamma interferon (IFN-gamma)/tumor necrosis factor alpha and IFN-gamma/interleukin-17 double-positiveChlamydia trachomatis control requires a vaccine.Evaluation of a multisubunit recombinant polymorphic membrane protein and major outer membrane protein T cell vaccine against Chlamydia muridarum genital infection in three strains of mice.Immunity to murine chlamydial genital infection.Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein by use of CpG oligodeoxynucleotides as an adjuvant induces a protective immune response against an intranasal chlamydial challengeCD4+ T cells and antibody are required for optimal major outer membrane protein vaccine-induced immunity to Chlamydia muridarum genital infection.Vaccination with the Chlamydia trachomatis major outer membrane protein can elicit an immune response as protective as that resulting from inoculation with live bacteria.Enhancement of the protective efficacy of a Chlamydia trachomatis recombinant vaccine by combining systemic and mucosal routes for immunization.Identification of immunodominant antigens by probing a whole Chlamydia trachomatis open reading frame proteome microarray using sera from immunized mice.Induction of immune memory by a multisubunit chlamydial vaccineVaccination against Chlamydia genital infection utilizing the murine C. muridarum model.Evaluation of a broadly protective Chlamydia-cholera combination vaccine candidate.Management of Chlamydia trachomatis genital tract infection: screening and treatment challenges.Chlamydia trachomatis vaccine research through the years.Structural and functional analyses of the major outer membrane protein of Chlamydia trachomatis.Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine.Delivery of Chlamydia vaccines.A multi-subunit Chlamydia vaccine inducing neutralizing antibodies and strong IFN-γ⁺ CMI responses protects against a genital infection in minipigsVaccination with the recombinant major outer membrane protein elicits antibodies to the constant domains and induces cross-serovar protection against intranasal challenge with Chlamydia trachomatis.A Multi-Component Prime-Boost Vaccination Regimen with a Consensus MOMP Antigen Enhances Chlamydia trachomatis Clearance.Chlamydia trachomatis recombinant MOMP encapsulated in PLGA nanoparticles triggers primarily T helper 1 cellular and antibody immune responses in mice: a desirable candidate nanovaccine.Protection of wild-type and severe combined immunodeficiency mice against an intranasal challenge by passive immunization with monoclonal antibodies to the Chlamydia trachomatis mouse pneumonitis major outer membrane protein.Immune-mediated control of Chlamydia infection.Vaccines for Chlamydia infections of the female genital tract.Role of CD8(+)T cells in the host response to ChlamydiaImmunity, immunopathology, and human vaccine development against sexually transmitted Chlamydia trachomatisCT043, a protective antigen that induces a CD4+ Th1 response during Chlamydia trachomatis infection in mice and humans.Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening.Assessment of the role in protection and pathogenesis of the Chlamydia muridarum V-type ATP synthase subunit A (AtpA) (TC0582).Genital Chlamydia trachomatis: understanding the roles of innate and adaptive immunity in vaccine research.Cell-free production of a functional oligomeric form of a chlamydia major outer membrane protein (MOMP) for vaccine development.Update on Chlamydia trachomatis Vaccinology.Subunit vaccines for the prevention of mucosal infection with Chlamydia trachomatis.Chlamydia vaccines: recent developments and the role of adjuvants in future formulations.Liposome delivery of Chlamydia muridarum major outer membrane protein primes a Th1 response that protects against genital chlamydial infection in a mouse model.
P2860
Q24793733-320546BC-29D5-42E6-84E9-056BCEBE7196Q24795726-211784AF-8A7E-46F5-A6D7-993C4A482370Q30152751-95602767-5A57-4C65-B2CB-95E5AFC6CF7EQ33588632-C0B9D0F2-F9A5-46EE-A948-CEA0768B1099Q33716094-833C141E-EC2F-444E-BE45-89D73E1639EBQ33826107-99D55AC4-44C9-427D-A762-6FB82A0E4D78Q34103774-F86FA887-4039-48EF-AB8C-341EE3AE698BQ34103785-B86BB781-17F9-45AA-8B39-C1B29B98D893Q34124225-B53FD442-1D92-48AE-AA9C-70C9AAA4579DQ34130795-DEFB5C6B-51CF-4ADE-A9F0-5D45F5CC4B95Q34177368-E52948FF-DE2A-4CF3-B6F7-F26625FBB76AQ34194679-0EDD7172-5B5F-4869-9EE5-0A49632D81B9Q34311438-CC7A21C5-C299-4BDC-B020-3AE6F51DA053Q34484641-9B2EC608-E4E4-4986-8DAB-03BA0FA02A12Q34546923-BDF5497D-BA25-4BD8-84C0-020A7C782E7EQ34739969-2E6B94CD-B569-4445-91D7-8B8B725B7BF1Q34883543-1772E14D-4061-4819-A732-FE8D4D4049D6Q35026625-87FACB11-97B7-4BA6-9F34-CF1BE3A68D0DQ35071155-AE296243-FB08-49A2-B446-18B258C5FACFQ35949509-EFBC58EC-6188-409D-8C17-6EFFDF1B4009Q36028197-5F05B479-B45B-448A-A79B-96CC941BC2C0Q36316798-6C849479-069A-4AD8-9AE2-F2F6921E88DAQ36564785-B368CD7E-BC24-4A99-9361-C7E75A3D1D78Q36827004-59AF518F-2737-4859-B038-BA927CC45DDEQ36845154-44B7C57C-EFF8-4D92-9B3F-6C81CEE06A90Q36929225-092DFEEC-BABE-403F-9AF1-8FFC1F7940A9Q36974443-207D6E0F-9270-42DE-8E19-B9D31B241B58Q36990773-87AC78E3-DE51-4E93-9B68-4C49C0680E3FQ37071155-B0061074-9FD1-4137-8678-DEDE3C1A60D3Q37093100-048C48C4-2EDF-4C92-A75A-727C89F92A77Q37159712-844D77EA-6CE0-4A02-82A5-F266011B627BQ37333434-48556A40-68C8-4C01-A9CA-8F6E973F5DE5Q37614736-6751943B-2189-4B85-AC77-E313C9504040Q37624678-B272AC72-EFC7-4706-96E1-2252EC82A520Q37712799-97723FF4-E091-4BE9-95D4-870E1EF5E97CQ37833759-5C775F83-14F3-4808-A7CF-D0F92D0281F6Q37834874-BE8DB8B6-9EA1-49B1-BC64-DD87D2DC9404Q37837221-D874D08B-3503-4021-9DE9-931369343A57Q37849913-12569B4F-7E93-4EFF-B794-5CEC86BCE06CQ37856989-1B3D65C8-F3C9-4529-A272-E2310BFB0ADC
P2860
Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein can elicit a protective immune response against a genital challenge
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Immunization with the Chlamydi ...... se against a genital challenge
@ast
Immunization with the Chlamydi ...... se against a genital challenge
@en
Immunization with the Chlamydi ...... se against a genital challenge
@nl
type
label
Immunization with the Chlamydi ...... se against a genital challenge
@ast
Immunization with the Chlamydi ...... se against a genital challenge
@en
Immunization with the Chlamydi ...... se against a genital challenge
@nl
prefLabel
Immunization with the Chlamydi ...... se against a genital challenge
@ast
Immunization with the Chlamydi ...... se against a genital challenge
@en
Immunization with the Chlamydi ...... se against a genital challenge
@nl
P2093
P2860
P1476
Immunization with the Chlamydi ...... se against a genital challenge
@en
P2093
E M Peterson
L M de la Maza
P2860
P304
P356
10.1128/IAI.69.10.6240-6247.2001
P407
P577
2001-10-01T00:00:00Z